Milestone Pharmaceuticals Inc. - Common Shares (MIST) analyst actions
Rating and price-target actions on MIST in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the MIST overview →
1 measured MIST analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Milestone Pharmaceuticals Initiates Pivotal Phase 3 Trial of Etripamil Nasal Spray for Self-Administered Treatment of Atrial Fibrillation with Rapid Ventricular Rate (AFib-RVR) | Press release | -2.34% | -1.40% |
Keep exploring
More MIST: earnings → · SEC filings → · MIST overview →